Sbir phase i: development of a novel biosensor to accelerate investigations of covid-19 and the GUT microbiome
Ended Project Grant Awarded Last action
- Award ID
- 2035981
- Recipient
-
Biomesense Inc. UEI MUZ4XK1Q1L15
- Awarding agency
-
Division of Industrial Innovation
National Science Foundation
- Obligated
- $255,658
Award facts
- Assistance listing
- 47.041 Engineering
- Completion date
- Funding agency
- National Science Foundation
- Place of performance
- Chicago, IL 60612, USA
Award details come from USAspending.gov.
About this award
Biomesense Inc. received a $255,658 National Science Foundation SBIR Phase I Project Grant to develop a novel biosensor to accelerate investigations of COVID-19 and the gut microbiome. Funded under the NSF Engineering program (CFDA 47.041), this six-month award beginning January 15, 2021 supports the company's work to design a portable, low-cost biosensor device capable of rapidly detecting SARS-CoV-2 and analyzing gut microbiome composition directly from patient samples. The NSF Directorate for Engineering seeks to improve quality of life and economic strength through innovative engineering research and education. This award advances those goals by expediting COVID-19 diagnostic testing and research on the virus's interaction with the human microbiome.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $255,658 |
Quick answers
Who received award 2035981?
2035981 was awarded to Biomesense Inc. by Division of Industrial Innovation (National Science Foundation) on January 15, 2021.
How much is award 2035981 worth?
$255,658 has been obligated on 2035981.
Which agency awarded 2035981?
Division of Industrial Innovation (National Science Foundation) awarded 2035981, with funding from National Science Foundation.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award